Interventional Cardiology Devices Market - Top Players and Growth Strategies | Industry Report 2022

-


Factors driving the growth of this market include the increasing incidence of cardiovascular diseases and the launch of innovative and technologically advanced interventional cardiology devices.

The interventional cardiology devices market is expected to reach USD 20.85 billion by 2022 from USD 14.52 billion in 2017, at a CAGR of 7.5%.

The interventional cardiology devices market is consolidated in nature due to the presence of a large number of players. The key players in the market are Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and Biotronik (Germany).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=548
Most companies in the interventional cardiology devices market adopted agreements, expansions, and product launches as the key business growth strategy. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2017. Some of the leading players who adopted these strategies include Cordis (US), Terumo (Japan), and Boston Scientific (US).

Medtronic is a medical technology company that offers a wide range of innovative products and therapies to treat more than 30 chronic diseases related to cardiac, diabetes, and neurological and spinal conditions. The company operates in two major segments, namely, Cardiac & Vascular Group and Restorative Therapies Group. The Cardiac and Vascular Group offers catheters, stents, and guidewires for the diagnosis and treatment of cardiovascular and peripheral vascular diseases. It also distributes its products through direct sales representatives in the US and a combination of direct and indirect sales representatives worldwide. It also adopts product launches as its organic growth strategy. Medtronic successfully commercialized balloon catheters and drug-eluting stents in 2015 and 2017, respectively.

Boston Scientific is a well-known player that develops, manufactures, and markets medical devices that are used in a broad range of interventional medical specialties. The company operates through three major segments, namely, Cardiovascular, Rhythm Management, and MedSurg. It also offers interventional cardiology devices through cardiovascular business segments. It also offers balloons, stents, and plaque modification devices for treating interventional cardiology diseases. The company operates in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It also partners with other private players to strengthen its product portfolio. In 2015, Boston Scientific partnered with C. R. Bard to distribute its Lutonix 035 Drug-coated Balloon in the US.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=548
Cordis is a medical device manufacturer that was acquired by Cardinal Health in 2015. It is involved in the development and production of innovative products and technologies for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. It also develops and markets devices for circulatory disease management, including stents, balloons, and catheters. The company adopts new partnerships and distribution agreements as its inorganic growth strategy. In 2017, Cordis partnered with Medinol Ltd. (Israel) to sell Medinol’s coronary stents portfolio in the US, which helped to re-establish Cordis in the interventional cardiology devices market.

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more